{"entity":{"type":"insider","cik":"0001861477","url":"/insider/0001861477","json_url":"/insider/0001861477.json","name":"Thompson Elizabeth H.Z.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":6,"first":"2021-08-06","last":"2026-07-31","span_basis":"filed_date"},"name_variants":[{"name":"Thompson Elizabeth H.Z.","source":"filing","n_filings":6,"first_seen":"2021-08-06","last_seen":"2026-07-31"}],"transactions":[{"id":5792259,"accession":"0001861477-26-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001861477-26-000005","line_url":"/filing/0001861477-26-000005","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001861477","owner_name":"Thompson Elizabeth H.Z.","owner_display_name":"Thompson Elizabeth H.Z.","owner_url":"/insider/0001861477","role":"Officer (EVP, Head of Research & Dev)","role_mark":"O","role_mark_label":"Officer (EVP, Head of Research & Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of Research & Dev","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16558.0,"shares_display":"16,558","price_per_share":26.130120787534725,"price_display":"26.13","price_state":"stated","total_value":432662.54,"total_display":"432,662.54","total_whole":"432,663","shares_owned_after":19044.0,"shares_owned_after_display":"19,044","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-30","filed_date":"2026-07-31","scope":"insider","n_lines":2},{"id":6032265,"accession":"0001861477-26-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001861477-26-000003","line_url":"/filing/0001861477-26-000003#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001861477","owner_name":"Thompson Elizabeth H.Z.","owner_display_name":"Thompson Elizabeth H.Z.","owner_url":"/insider/0001861477","role":"Officer (EVP, Head of Research & Dev)","role_mark":"O","role_mark_label":"Officer (EVP, Head of Research & Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Head of Research & Dev","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3435.0,"shares_display":"3,435","price_per_share":21.47,"price_display":"21.47","price_state":"stated","total_value":73749.45,"total_display":"73,749.45","total_whole":"73,749","shares_owned_after":3280.0,"shares_owned_after_display":"3,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-25","filed_date":"2026-03-26","scope":"insider"},{"id":6497130,"accession":"0001209191-22-042767","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-042767","line_url":"/filing/0001209191-22-042767#line-3","is_derivative":false,"issuer_cik":"0001492426","issuer_name":"Horizon Therapeutics Public Ltd Co","issuer_ticker":"HZNP","issuer_name_source":null,"issuer_url":"/issuer/0001492426","owner_cik":"0001861477","owner_name":"Thompson Elizabeth H.Z.","owner_display_name":"Thompson Elizabeth H.Z.","owner_url":"/insider/0001861477","role":"Officer (EVP, Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5917.0,"shares_display":"5,917","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":502945.0,"total_display":"502,945.00","total_whole":"502,945","shares_owned_after":6969.0,"shares_owned_after_display":"6,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-20","filed_date":"2022-07-20","scope":"insider"},{"id":6497128,"accession":"0001209191-22-042767","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-042767","line_url":"/filing/0001209191-22-042767","is_derivative":false,"issuer_cik":"0001492426","issuer_name":"Horizon Therapeutics Public Ltd Co","issuer_ticker":"HZNP","issuer_name_source":null,"issuer_url":"/issuer/0001492426","owner_cik":"0001861477","owner_name":"Thompson Elizabeth H.Z.","owner_display_name":"Thompson Elizabeth H.Z.","owner_url":"/insider/0001861477","role":"Officer (EVP, Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90.0,"shares_display":"90","price_per_share":85.03777777777778,"price_display":"85.04","price_state":"stated","total_value":7653.4,"total_display":"7,653.40","total_whole":"7,653","shares_owned_after":12886.0,"shares_owned_after_display":"12,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-19","filed_date":"2022-07-20","scope":"insider","n_lines":2},{"id":6612761,"accession":"0001209191-22-041840","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-041840","line_url":"/filing/0001209191-22-041840#line-1","is_derivative":false,"issuer_cik":"0001492426","issuer_name":"Horizon Therapeutics Public Ltd Co","issuer_ticker":"HZNP","issuer_name_source":null,"issuer_url":"/issuer/0001492426","owner_cik":"0001861477","owner_name":"Thompson Elizabeth H.Z.","owner_display_name":"Thompson Elizabeth H.Z.","owner_url":"/insider/0001861477","role":"Officer (EVP, Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82.0,"shares_display":"82","price_per_share":85.01,"price_display":"85.01","price_state":"stated","total_value":6970.82,"total_display":"6,970.82","total_whole":"6,971","shares_owned_after":12976.0,"shares_owned_after_display":"12,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-07","filed_date":"2022-07-11","scope":"insider"},{"id":6429276,"accession":"0001209191-22-024924","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-024924","line_url":"/filing/0001209191-22-024924#line-1","is_derivative":false,"issuer_cik":"0001492426","issuer_name":"Horizon Therapeutics Public Ltd Co","issuer_ticker":"HZNP","issuer_name_source":null,"issuer_url":"/issuer/0001492426","owner_cik":"0001861477","owner_name":"Thompson Elizabeth H.Z.","owner_display_name":"Thompson Elizabeth H.Z.","owner_url":"/insider/0001861477","role":"Officer (EVP, Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8098.0,"shares_display":"8,098","price_per_share":115.64,"price_display":"115.64","price_state":"stated","total_value":936452.72,"total_display":"936,452.72","total_whole":"936,453","shares_owned_after":13058.0,"shares_owned_after_display":"13,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-18","filed_date":"2022-04-20","scope":"insider"},{"id":4623490,"accession":"0001209191-21-050212","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-050212","line_url":"/filing/0001209191-21-050212#line-1","is_derivative":false,"issuer_cik":"0001492426","issuer_name":"Horizon Therapeutics Public Ltd Co","issuer_ticker":"HZNP","issuer_name_source":null,"issuer_url":"/issuer/0001492426","owner_cik":"0001861477","owner_name":"Thompson Elizabeth H.Z.","owner_display_name":"Thompson Elizabeth H.Z.","owner_url":"/insider/0001861477","role":"Officer (EVP, Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Development","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7542.0,"shares_display":"7,542","price_per_share":106.3411,"price_display":"106.34","price_state":"stated","total_value":802024.5762,"total_display":"802,024.58","total_whole":"802,025","shares_owned_after":14187.0,"shares_owned_after_display":"14,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-05","filed_date":"2021-08-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Officer (EVP, Head of Research & Dev)","n_filings":2,"first_seen":"2026-03-26","last_seen":"2026-07-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001492426","name":"Horizon Therapeutics Public Ltd Co","url":"/issuer/0001492426","role":"Officer (EVP, Research & Development)","n_filings":4,"first_seen":"2021-08-06","last_seen":"2022-07-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001861477","retrieved_at":"2026-08-26T20:28:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}